EXHIBIT 99.3


                              FORM OF CERTIFICATION

                      CERTIFICATION PURSUANT TO SECTION 906
                        OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report on Form 10-Q of DOR BioPharma,
Inc. (the "Company") for the quarterly period ended March 31, 2003 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
William D. Milling, Controller and Principal Financial Officer of the Company,
certify, pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1)      the Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      the information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Company.


By:       /s/ William D. Milling
         -----------------------
Name:    William D. Milling
         Controller, Principle Financial Officer
May 15, 2003


         A signed original of this written statement required by Section 906 has
been provided to DOR BioPharma, Inc. and will be retained by DOR BioPharma, Inc.
and furnished to the Securities and Exchange Commission or its staff upon
request